Treatment of lower urinary tract symptoms suggestive of benign prostatic hyperplasia: the cardiovascular system

BJU Int. 2005 Jun:95 Suppl 4:19-28. doi: 10.1111/j.1464-410X.2005.05487.x.
No abstract available

Publication types

  • Review

MeSH terms

  • Adrenergic alpha-Antagonists / adverse effects
  • Adrenergic alpha-Antagonists / therapeutic use*
  • Aged
  • Antihypertensive Agents / therapeutic use
  • Cardiovascular Diseases / chemically induced
  • Cardiovascular Diseases / prevention & control
  • Drug Interactions
  • Humans
  • Male
  • Middle Aged
  • Phosphodiesterase Inhibitors / therapeutic use
  • Prostatic Hyperplasia / drug therapy*
  • Risk Factors

Substances

  • Adrenergic alpha-Antagonists
  • Antihypertensive Agents
  • Phosphodiesterase Inhibitors